A drug with the SMILES C[C@@H]1C(=O)O[C@@H]2[C@H](O)C34[C@@H]5OC(=O)C3(O[C@H]3OC(=O)[C@H](O)C34[C@H](C(C)(C)C)[C@H]5O)[C@@]12O has a hERG inhibition at a concentration of 10uM of 35.126%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_10uM__names__noun} of {herg_central_at_10uM#}{herg_central_at_10uM__units}.
C[C@@H]1C(=O)O[C@@H]2[C@H](O)C34[C@@H]5OC(=O)C3(O[C@H]3OC(=O)[C@H](O)C34[C@H](C(C)(C)C)[C@H]5O)[C@@]12O
C[C@@H]1C(=O)O[C@@H]2[C@H](O)C34[C@@H]5OC(=O)C3(O[C@H]3OC(=O)[C@H](O)C34[C@H](C(C)(C)C)[C@H]5O)[C@@]12O
(3S,6R,8S,9R,10S,12R,13R,16S,17R)-8-tert-butyl-6,9,12,17-tetrahydroxy-16-methyl-2,4,14,19-tetraoxahexacyclo[8.7.2.01,11.03,7.07,11.013,17]nonadecane-5,15,18-trione